nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CALM3—ulcerative colitis	0.0029	0.00977	CbGpPWpGaD
Acamprosate—GRIN1—Post NMDA receptor activation events—CALM3—ulcerative colitis	0.00275	0.00925	CbGpPWpGaD
Acamprosate—GRIN2B—Post NMDA receptor activation events—CALM3—ulcerative colitis	0.00268	0.00902	CbGpPWpGaD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CALM3—ulcerative colitis	0.00253	0.00852	CbGpPWpGaD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CALM3—ulcerative colitis	0.00247	0.00831	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—CALM3—ulcerative colitis	0.00225	0.00757	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.00223	0.0075	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.00223	0.0075	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—CALM3—ulcerative colitis	0.00209	0.00704	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MIF—ulcerative colitis	0.00202	0.00681	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.00192	0.00647	CbGpPWpGaD
Acamprosate—GRM5—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00182	0.00613	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—CALM3—ulcerative colitis	0.00172	0.00578	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00163	0.00549	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCR1—ulcerative colitis	0.00155	0.00522	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—CALM3—ulcerative colitis	0.0015	0.00504	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CALM3—ulcerative colitis	0.00146	0.00491	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.00142	0.00479	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.00139	0.00467	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL20—ulcerative colitis	0.00136	0.00458	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.00133	0.00447	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—FCGR2A—ulcerative colitis	0.00133	0.00447	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.00132	0.00445	CbGpPWpGaD
Acamprosate—GRIN2B—ErbB4 signaling events—JAK2—ulcerative colitis	0.00127	0.00426	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCR2—ulcerative colitis	0.00121	0.00408	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCR6—ulcerative colitis	0.00114	0.00384	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.00113	0.00381	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.00113	0.00381	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ARPC2—ulcerative colitis	0.00111	0.00375	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.00109	0.00366	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ARPC2—ulcerative colitis	0.00108	0.00365	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.00107	0.0036	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.00103	0.00348	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—PTGER4—ulcerative colitis	0.001	0.00338	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000994	0.00335	CbGpPWpGaD
Acamprosate—GABRB3—GABA receptor activation—ADCY5—ulcerative colitis	0.000986	0.00332	CbGpPWpGaD
Acamprosate—GABRG2—GABA receptor activation—ADCY5—ulcerative colitis	0.000968	0.00326	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.000959	0.00323	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000947	0.00319	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000923	0.00311	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—GHRL—ulcerative colitis	0.000919	0.00309	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—IL1B—ulcerative colitis	0.00089	0.003	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000875	0.00295	CbGpPWpGaD
Acamprosate—GABRA1—GABA receptor activation—ADCY5—ulcerative colitis	0.000846	0.00285	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—IL1B—ulcerative colitis	0.000828	0.00279	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CALM3—ulcerative colitis	0.000819	0.00276	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000816	0.00275	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—LAMB1—ulcerative colitis	0.000796	0.00268	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCR1—ulcerative colitis	0.000795	0.00268	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ARPC2—ulcerative colitis	0.000794	0.00267	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.000788	0.00265	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—LAMB1—ulcerative colitis	0.000776	0.00261	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000776	0.00261	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ARPC2—ulcerative colitis	0.000774	0.00261	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NR5A2—ulcerative colitis	0.00077	0.00259	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCL20—ulcerative colitis	0.000769	0.00259	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CALM3—ulcerative colitis	0.000762	0.00257	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—ADRB2—ulcerative colitis	0.00076	0.00256	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.000752	0.00253	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NR5A2—ulcerative colitis	0.000751	0.00253	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GNA12—ulcerative colitis	0.000723	0.00243	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000721	0.00243	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000714	0.0024	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000712	0.0024	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000712	0.0024	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000705	0.00237	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.0007	0.00236	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL20—ulcerative colitis	0.000698	0.00235	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000694	0.00234	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.000687	0.00231	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000685	0.00231	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—ulcerative colitis	0.00068	0.00229	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.00067	0.00226	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TLR4—ulcerative colitis	0.000661	0.00223	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GNA12—ulcerative colitis	0.000656	0.00221	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.000656	0.00221	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—ulcerative colitis	0.000646	0.00218	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR6—ulcerative colitis	0.000644	0.00217	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—ICAM1—ulcerative colitis	0.000634	0.00213	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CALM3—ulcerative colitis	0.000626	0.00211	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000625	0.0021	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCR2—ulcerative colitis	0.000622	0.00209	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000614	0.00207	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000611	0.00206	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—ulcerative colitis	0.000601	0.00202	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—ADCY5—ulcerative colitis	0.000594	0.002	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—ulcerative colitis	0.000593	0.002	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000592	0.00199	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR6—ulcerative colitis	0.000585	0.00197	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—ulcerative colitis	0.000578	0.00195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SEL1L—ulcerative colitis	0.00057	0.00192	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TP53—ulcerative colitis	0.00057	0.00192	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LAMB1—ulcerative colitis	0.000568	0.00191	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000567	0.00191	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LAMB1—ulcerative colitis	0.000554	0.00186	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—ADCY5—ulcerative colitis	0.000553	0.00186	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CALM3—ulcerative colitis	0.000546	0.00184	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM3—ulcerative colitis	0.000536	0.00181	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CALM3—ulcerative colitis	0.000532	0.00179	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—ulcerative colitis	0.000529	0.00178	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GHRL—ulcerative colitis	0.000519	0.00175	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000517	0.00174	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PTGER4—ulcerative colitis	0.000515	0.00173	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000504	0.0017	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.0005	0.00168	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TCF4—ulcerative colitis	0.000496	0.00167	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—ulcerative colitis	0.000493	0.00166	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—ulcerative colitis	0.000486	0.00164	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TCF4—ulcerative colitis	0.000484	0.00163	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—ulcerative colitis	0.000482	0.00162	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—ulcerative colitis	0.000474	0.0016	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GHRL—ulcerative colitis	0.000471	0.00159	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.00047	0.00158	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCR1—ulcerative colitis	0.00047	0.00158	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—ulcerative colitis	0.000462	0.00156	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000461	0.00155	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CALM3—ulcerative colitis	0.000457	0.00154	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—ADCY5—ulcerative colitis	0.000454	0.00153	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.000453	0.00153	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—ulcerative colitis	0.000448	0.00151	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.000445	0.0015	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—ulcerative colitis	0.000435	0.00146	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HNF4A—ulcerative colitis	0.00043	0.00145	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—ulcerative colitis	0.00043	0.00145	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—ulcerative colitis	0.00043	0.00145	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00043	0.00145	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—ulcerative colitis	0.000428	0.00144	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.00042	0.00141	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.00042	0.00141	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HNF4A—ulcerative colitis	0.00042	0.00141	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—ulcerative colitis	0.000419	0.00141	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—JAK2—ulcerative colitis	0.000419	0.00141	CbGpPWpGaD
Acamprosate—Dizziness—Azathioprine—ulcerative colitis	0.000418	0.000594	CcSEcCtD
Acamprosate—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000415	0.00059	CcSEcCtD
Acamprosate—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000414	0.000589	CcSEcCtD
Acamprosate—Asthenia—Mesalazine—ulcerative colitis	0.000413	0.000587	CcSEcCtD
Acamprosate—Shock—Prednisolone—ulcerative colitis	0.000412	0.000587	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000412	0.00139	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000412	0.00139	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL20—ulcerative colitis	0.000412	0.00139	CbGpPWpGaD
Acamprosate—Cough—Triamcinolone—ulcerative colitis	0.000412	0.000586	CcSEcCtD
Acamprosate—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000409	0.000582	CcSEcCtD
Acamprosate—Convulsion—Triamcinolone—ulcerative colitis	0.000409	0.000582	CcSEcCtD
Acamprosate—Tachycardia—Prednisolone—ulcerative colitis	0.000409	0.000582	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—JAK2—ulcerative colitis	0.000408	0.00138	CbGpPWpGaD
Acamprosate—Convulsion—Methylprednisolone—ulcerative colitis	0.000408	0.000581	CcSEcCtD
Acamprosate—Hypertension—Triamcinolone—ulcerative colitis	0.000408	0.00058	CcSEcCtD
Acamprosate—Pruritus—Mesalazine—ulcerative colitis	0.000407	0.000579	CcSEcCtD
Acamprosate—Hypertension—Methylprednisolone—ulcerative colitis	0.000407	0.000579	CcSEcCtD
Acamprosate—Infection—Hydrocortisone—ulcerative colitis	0.000407	0.000578	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000406	0.00137	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—RELA—ulcerative colitis	0.000406	0.00137	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—ulcerative colitis	0.000405	0.00137	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000405	0.000576	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000403	0.00136	CbGpPWpGaD
Acamprosate—Shock—Hydrocortisone—ulcerative colitis	0.000403	0.000573	CcSEcCtD
Acamprosate—Myalgia—Triamcinolone—ulcerative colitis	0.000402	0.000572	CcSEcCtD
Acamprosate—Vomiting—Azathioprine—ulcerative colitis	0.000402	0.000572	CcSEcCtD
Acamprosate—Arthralgia—Methylprednisolone—ulcerative colitis	0.000401	0.000571	CcSEcCtD
Acamprosate—Myalgia—Methylprednisolone—ulcerative colitis	0.000401	0.000571	CcSEcCtD
Acamprosate—Anxiety—Methylprednisolone—ulcerative colitis	0.0004	0.000569	CcSEcCtD
Acamprosate—Tachycardia—Hydrocortisone—ulcerative colitis	0.000399	0.000568	CcSEcCtD
Acamprosate—Rash—Azathioprine—ulcerative colitis	0.000398	0.000567	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000398	0.000567	CcSEcCtD
Acamprosate—Dermatitis—Azathioprine—ulcerative colitis	0.000398	0.000566	CcSEcCtD
Acamprosate—Skin disorder—Hydrocortisone—ulcerative colitis	0.000398	0.000566	CcSEcCtD
Acamprosate—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000398	0.000566	CcSEcCtD
Acamprosate—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000398	0.000566	CcSEcCtD
Acamprosate—Discomfort—Triamcinolone—ulcerative colitis	0.000397	0.000565	CcSEcCtD
Acamprosate—Discomfort—Methylprednisolone—ulcerative colitis	0.000396	0.000564	CcSEcCtD
Acamprosate—Headache—Azathioprine—ulcerative colitis	0.000396	0.000563	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—ADCY5—ulcerative colitis	0.000396	0.00133	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000396	0.000563	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—RELA—ulcerative colitis	0.000395	0.00133	CbGpPWpGaD
Acamprosate—Diarrhoea—Mesalazine—ulcerative colitis	0.000394	0.00056	CcSEcCtD
Acamprosate—Dry mouth—Triamcinolone—ulcerative colitis	0.000393	0.000559	CcSEcCtD
Acamprosate—Angioedema—Dexamethasone—ulcerative colitis	0.000392	0.000557	CcSEcCtD
Acamprosate—Angioedema—Betamethasone—ulcerative colitis	0.000392	0.000557	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—ADRB2—ulcerative colitis	0.00039	0.00131	CbGpPWpGaD
Acamprosate—Anorexia—Hydrocortisone—ulcerative colitis	0.00039	0.000555	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—ulcerative colitis	0.000389	0.00131	CbGpPWpGaD
Acamprosate—Confusional state—Methylprednisolone—ulcerative colitis	0.000388	0.000552	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GNA12—ulcerative colitis	0.000388	0.00131	CbGpPWpGaD
Acamprosate—Immune system disorder—Prednisone—ulcerative colitis	0.000387	0.000551	CcSEcCtD
Acamprosate—Malaise—Betamethasone—ulcerative colitis	0.000386	0.00055	CcSEcCtD
Acamprosate—Malaise—Dexamethasone—ulcerative colitis	0.000386	0.00055	CcSEcCtD
Acamprosate—GRIN2B—Neuronal System—ADCY5—ulcerative colitis	0.000386	0.0013	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000385	0.000548	CcSEcCtD
Acamprosate—Vertigo—Dexamethasone—ulcerative colitis	0.000385	0.000548	CcSEcCtD
Acamprosate—Vertigo—Betamethasone—ulcerative colitis	0.000385	0.000548	CcSEcCtD
Acamprosate—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000385	0.000547	CcSEcCtD
Acamprosate—Syncope—Dexamethasone—ulcerative colitis	0.000384	0.000547	CcSEcCtD
Acamprosate—Syncope—Betamethasone—ulcerative colitis	0.000384	0.000547	CcSEcCtD
Acamprosate—Infection—Triamcinolone—ulcerative colitis	0.000383	0.000545	CcSEcCtD
Acamprosate—Hypotension—Hydrocortisone—ulcerative colitis	0.000382	0.000544	CcSEcCtD
Acamprosate—Infection—Methylprednisolone—ulcerative colitis	0.000382	0.000543	CcSEcCtD
Acamprosate—Dizziness—Mesalazine—ulcerative colitis	0.000381	0.000541	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TP53—ulcerative colitis	0.000379	0.00128	CbGpPWpGaD
Acamprosate—Shock—Triamcinolone—ulcerative colitis	0.000379	0.000539	CcSEcCtD
Acamprosate—Insomnia—Prednisolone—ulcerative colitis	0.000379	0.000539	CcSEcCtD
Acamprosate—Alopecia—Prednisone—ulcerative colitis	0.000379	0.000539	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000379	0.00128	CbGpPWpGaD
Acamprosate—Shock—Methylprednisolone—ulcerative colitis	0.000378	0.000538	CcSEcCtD
Acamprosate—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000377	0.000536	CcSEcCtD
Acamprosate—Loss of consciousness—Betamethasone—ulcerative colitis	0.000377	0.000536	CcSEcCtD
Acamprosate—Paraesthesia—Prednisolone—ulcerative colitis	0.000376	0.000535	CcSEcCtD
Acamprosate—Tachycardia—Triamcinolone—ulcerative colitis	0.000376	0.000535	CcSEcCtD
Acamprosate—Mental disorder—Prednisone—ulcerative colitis	0.000376	0.000534	CcSEcCtD
Acamprosate—Nausea—Azathioprine—ulcerative colitis	0.000375	0.000534	CcSEcCtD
Acamprosate—Tachycardia—Methylprednisolone—ulcerative colitis	0.000375	0.000534	CcSEcCtD
Acamprosate—Skin disorder—Methylprednisolone—ulcerative colitis	0.000374	0.000531	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—ulcerative colitis	0.000373	0.000531	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000373	0.00053	CcSEcCtD
Acamprosate—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000373	0.00053	CcSEcCtD
Acamprosate—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000372	0.000529	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.000371	0.00125	CbGpPWpGaD
Acamprosate—Convulsion—Betamethasone—ulcerative colitis	0.000371	0.000528	CcSEcCtD
Acamprosate—Convulsion—Dexamethasone—ulcerative colitis	0.000371	0.000528	CcSEcCtD
Acamprosate—Insomnia—Hydrocortisone—ulcerative colitis	0.00037	0.000527	CcSEcCtD
Acamprosate—Hypertension—Betamethasone—ulcerative colitis	0.00037	0.000526	CcSEcCtD
Acamprosate—Hypertension—Dexamethasone—ulcerative colitis	0.00037	0.000526	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—ulcerative colitis	0.00037	0.00125	CbGpPWpGaD
Acamprosate—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000368	0.000523	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CXCR2—ulcerative colitis	0.000367	0.00124	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—ulcerative colitis	0.000367	0.00124	CbGpPWpGaD
Acamprosate—Vomiting—Mesalazine—ulcerative colitis	0.000366	0.000521	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000366	0.00123	CbGpPWpGaD
Acamprosate—Myalgia—Dexamethasone—ulcerative colitis	0.000365	0.000519	CcSEcCtD
Acamprosate—Myalgia—Betamethasone—ulcerative colitis	0.000365	0.000519	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000365	0.00123	CbGpPWpGaD
Acamprosate—Anxiety—Betamethasone—ulcerative colitis	0.000364	0.000517	CcSEcCtD
Acamprosate—Anxiety—Dexamethasone—ulcerative colitis	0.000364	0.000517	CcSEcCtD
Acamprosate—Rash—Mesalazine—ulcerative colitis	0.000363	0.000516	CcSEcCtD
Acamprosate—Dermatitis—Mesalazine—ulcerative colitis	0.000363	0.000516	CcSEcCtD
Acamprosate—Headache—Mesalazine—ulcerative colitis	0.000361	0.000513	CcSEcCtD
Acamprosate—Discomfort—Dexamethasone—ulcerative colitis	0.00036	0.000513	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—ulcerative colitis	0.00036	0.000513	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.00036	0.00121	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.00036	0.00121	CbGpPWpGaD
Acamprosate—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00036	0.000513	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—CALM3—ulcerative colitis	0.00036	0.00121	CbGpPWpGaD
Acamprosate—Hypotension—Methylprednisolone—ulcerative colitis	0.000359	0.000511	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.000359	0.00121	CbGpPWpGaD
Acamprosate—Pain—Prednisolone—ulcerative colitis	0.000358	0.00051	CcSEcCtD
Acamprosate—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000356	0.000506	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—CALM3—ulcerative colitis	0.000353	0.00119	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000353	0.000503	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000351	0.000499	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00035	0.000498	CcSEcCtD
Acamprosate—Pain—Hydrocortisone—ulcerative colitis	0.00035	0.000498	CcSEcCtD
Acamprosate—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.00035	0.000497	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—ulcerative colitis	0.00035	0.000497	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—ulcerative colitis	0.000349	0.000496	CcSEcCtD
Acamprosate—Insomnia—Methylprednisolone—ulcerative colitis	0.000348	0.000495	CcSEcCtD
Acamprosate—Infection—Betamethasone—ulcerative colitis	0.000347	0.000494	CcSEcCtD
Acamprosate—Infection—Dexamethasone—ulcerative colitis	0.000347	0.000494	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—ulcerative colitis	0.000346	0.000492	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—ulcerative colitis	0.000346	0.000492	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CCR6—ulcerative colitis	0.000345	0.00116	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisolone—ulcerative colitis	0.000345	0.000491	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000345	0.000491	CcSEcCtD
Acamprosate—Anaemia—Prednisone—ulcerative colitis	0.000345	0.000491	CcSEcCtD
Acamprosate—Shock—Betamethasone—ulcerative colitis	0.000344	0.000489	CcSEcCtD
Acamprosate—Shock—Dexamethasone—ulcerative colitis	0.000344	0.000489	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.000344	0.00116	CbGpPWpGaD
Acamprosate—Dyspnoea—Triamcinolone—ulcerative colitis	0.000344	0.000489	CcSEcCtD
Acamprosate—Agitation—Prednisone—ulcerative colitis	0.000343	0.000488	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000342	0.000487	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000342	0.000487	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—NFKB1—ulcerative colitis	0.000342	0.00115	CbGpPWpGaD
Acamprosate—Nausea—Mesalazine—ulcerative colitis	0.000342	0.000486	CcSEcCtD
Acamprosate—Tachycardia—Dexamethasone—ulcerative colitis	0.000341	0.000485	CcSEcCtD
Acamprosate—Tachycardia—Betamethasone—ulcerative colitis	0.000341	0.000485	CcSEcCtD
Acamprosate—Angioedema—Prednisone—ulcerative colitis	0.000341	0.000485	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000341	0.00115	CbGpPWpGaD
Acamprosate—Dyspepsia—Triamcinolone—ulcerative colitis	0.000339	0.000483	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000339	0.000482	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000338	0.000481	CcSEcCtD
Acamprosate—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000338	0.000481	CcSEcCtD
Acamprosate—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000337	0.00048	CcSEcCtD
Acamprosate—Malaise—Prednisone—ulcerative colitis	0.000337	0.000479	CcSEcCtD
Acamprosate—Vertigo—Prednisone—ulcerative colitis	0.000335	0.000477	CcSEcCtD
Acamprosate—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000335	0.000476	CcSEcCtD
Acamprosate—GABRG2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000335	0.00113	CbGpPWpGaD
Acamprosate—Syncope—Prednisone—ulcerative colitis	0.000335	0.000476	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—ulcerative colitis	0.000334	0.00113	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NFKB1—ulcerative colitis	0.000333	0.00112	CbGpPWpGaD
Acamprosate—Anorexia—Betamethasone—ulcerative colitis	0.000333	0.000474	CcSEcCtD
Acamprosate—Anorexia—Dexamethasone—ulcerative colitis	0.000333	0.000474	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—ulcerative colitis	0.000333	0.000474	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—ADCY5—ulcerative colitis	0.000331	0.00112	CbGpPWpGaD
Acamprosate—Pain—Triamcinolone—ulcerative colitis	0.00033	0.000469	CcSEcCtD
Acamprosate—Loss of consciousness—Prednisone—ulcerative colitis	0.000328	0.000467	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—MAML2—ulcerative colitis	0.000328	0.0011	CbGpPWpGaD
Acamprosate—Hypotension—Dexamethasone—ulcerative colitis	0.000327	0.000465	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—ulcerative colitis	0.000327	0.000465	CcSEcCtD
Acamprosate—Urticaria—Hydrocortisone—ulcerative colitis	0.000325	0.000463	CcSEcCtD
Acamprosate—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000324	0.00046	CcSEcCtD
Acamprosate—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000324	0.00046	CcSEcCtD
Acamprosate—Convulsion—Prednisone—ulcerative colitis	0.000323	0.00046	CcSEcCtD
Acamprosate—Hypertension—Prednisone—ulcerative colitis	0.000322	0.000458	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000321	0.00108	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000319	0.000453	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000319	0.000453	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—ulcerative colitis	0.000318	0.000452	CcSEcCtD
Acamprosate—Myalgia—Prednisone—ulcerative colitis	0.000318	0.000452	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000318	0.000452	CcSEcCtD
Acamprosate—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000317	0.000451	CcSEcCtD
Acamprosate—Anxiety—Prednisone—ulcerative colitis	0.000317	0.00045	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—ulcerative colitis	0.000316	0.00045	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—ulcerative colitis	0.000316	0.00045	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000316	0.000449	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000314	0.000447	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—ulcerative colitis	0.000314	0.000447	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—ulcerative colitis	0.000314	0.000447	CcSEcCtD
Acamprosate—Discomfort—Prednisone—ulcerative colitis	0.000314	0.000446	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—ulcerative colitis	0.000312	0.00105	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CALM3—ulcerative colitis	0.000309	0.00104	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisolone—ulcerative colitis	0.000309	0.000439	CcSEcCtD
Acamprosate—Dyspepsia—Dexamethasone—ulcerative colitis	0.000308	0.000438	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—ulcerative colitis	0.000308	0.000438	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—ulcerative colitis	0.000307	0.00104	CbGpPWpGaD
Acamprosate—Urticaria—Triamcinolone—ulcerative colitis	0.000306	0.000436	CcSEcCtD
Acamprosate—Urticaria—Methylprednisolone—ulcerative colitis	0.000306	0.000435	CcSEcCtD
Acamprosate—Body temperature increased—Triamcinolone—ulcerative colitis	0.000305	0.000433	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—ulcerative colitis	0.000305	0.000433	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PTGER4—ulcerative colitis	0.000304	0.00102	CbGpPWpGaD
Acamprosate—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000304	0.000432	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—ulcerative colitis	0.000304	0.000432	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—ulcerative colitis	0.000304	0.000432	CcSEcCtD
Acamprosate—Infection—Prednisone—ulcerative colitis	0.000303	0.00043	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000302	0.000429	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000302	0.000429	CcSEcCtD
Acamprosate—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000302	0.000429	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—ulcerative colitis	0.0003	0.00101	CbGpPWpGaD
Acamprosate—Shock—Prednisone—ulcerative colitis	0.0003	0.000426	CcSEcCtD
Acamprosate—Pain—Dexamethasone—ulcerative colitis	0.000299	0.000425	CcSEcCtD
Acamprosate—Pain—Betamethasone—ulcerative colitis	0.000299	0.000425	CcSEcCtD
Acamprosate—Tachycardia—Prednisone—ulcerative colitis	0.000297	0.000423	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—ulcerative colitis	0.000296	0.000421	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—ulcerative colitis	0.000294	0.000419	CcSEcCtD
Acamprosate—Asthenia—Hydrocortisone—ulcerative colitis	0.000294	0.000418	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	0.000293	0.000985	CbGpPWpGaD
Acamprosate—Anorexia—Prednisone—ulcerative colitis	0.00029	0.000413	CcSEcCtD
Acamprosate—Pruritus—Hydrocortisone—ulcerative colitis	0.00029	0.000412	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—ulcerative colitis	0.000288	0.00041	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000288	0.00041	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000286	0.000407	CcSEcCtD
Acamprosate—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000286	0.000407	CcSEcCtD
Acamprosate—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000284	0.000404	CcSEcCtD
Acamprosate—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000283	0.000403	CcSEcCtD
Acamprosate—Diarrhoea—Hydrocortisone—ulcerative colitis	0.00028	0.000398	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GHRL—ulcerative colitis	0.000278	0.000938	CbGpPWpGaD
Acamprosate—Urticaria—Dexamethasone—ulcerative colitis	0.000278	0.000395	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—ulcerative colitis	0.000278	0.000395	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000277	0.000395	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—ulcerative colitis	0.000277	0.000394	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—ulcerative colitis	0.000277	0.000393	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—ulcerative colitis	0.000276	0.000393	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—ulcerative colitis	0.000276	0.000393	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—ulcerative colitis	0.000276	0.000393	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—ulcerative colitis	0.000276	0.000393	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—JAK2—ulcerative colitis	0.000276	0.000931	CbGpPWpGaD
Acamprosate—Asthenia—Methylprednisolone—ulcerative colitis	0.000276	0.000392	CcSEcCtD
Acamprosate—Insomnia—Prednisone—ulcerative colitis	0.000275	0.000392	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—ulcerative colitis	0.000275	0.000926	CbGpPWpGaD
Acamprosate—Paraesthesia—Prednisone—ulcerative colitis	0.000273	0.000389	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—ulcerative colitis	0.000273	0.000388	CcSEcCtD
Acamprosate—Pruritus—Methylprednisolone—ulcerative colitis	0.000272	0.000387	CcSEcCtD
Acamprosate—Dizziness—Hydrocortisone—ulcerative colitis	0.000271	0.000385	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CALM3—ulcerative colitis	0.00027	0.000908	CbGpPWpGaD
Acamprosate—Dyspepsia—Prednisone—ulcerative colitis	0.000268	0.000381	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—RELA—ulcerative colitis	0.000268	0.000901	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RIPK2—ulcerative colitis	0.000266	0.000895	CbGpPWpGaD
Acamprosate—Decreased appetite—Prednisone—ulcerative colitis	0.000265	0.000377	CcSEcCtD
Acamprosate—Rash—Prednisolone—ulcerative colitis	0.000264	0.000376	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—ulcerative colitis	0.000264	0.000376	CcSEcCtD
Acamprosate—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000263	0.000374	CcSEcCtD
Acamprosate—Headache—Prednisolone—ulcerative colitis	0.000263	0.000373	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000261	0.000881	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—ADCY5—ulcerative colitis	0.000261	0.000879	CbGpPWpGaD
Acamprosate—Constipation—Prednisone—ulcerative colitis	0.00026	0.00037	CcSEcCtD
Acamprosate—Vomiting—Hydrocortisone—ulcerative colitis	0.00026	0.00037	CcSEcCtD
Acamprosate—Rash—Hydrocortisone—ulcerative colitis	0.000258	0.000367	CcSEcCtD
Acamprosate—Dermatitis—Hydrocortisone—ulcerative colitis	0.000258	0.000367	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000257	0.000865	CbGpPWpGaD
Acamprosate—Headache—Hydrocortisone—ulcerative colitis	0.000256	0.000365	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—ADCY5—ulcerative colitis	0.000256	0.000863	CbGpPWpGaD
Acamprosate—Dizziness—Triamcinolone—ulcerative colitis	0.000255	0.000363	CcSEcCtD
Acamprosate—Dizziness—Methylprednisolone—ulcerative colitis	0.000254	0.000362	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000254	0.000855	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—ulcerative colitis	0.000252	0.000848	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisone—ulcerative colitis	0.000251	0.000357	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—ulcerative colitis	0.000251	0.000357	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—ulcerative colitis	0.000251	0.000357	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.00025	0.000841	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000249	0.000354	CcSEcCtD
Acamprosate—Nausea—Prednisolone—ulcerative colitis	0.000249	0.000354	CcSEcCtD
Acamprosate—Pruritus—Dexamethasone—ulcerative colitis	0.000247	0.000352	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—ulcerative colitis	0.000247	0.000352	CcSEcCtD
Acamprosate—Vomiting—Triamcinolone—ulcerative colitis	0.000245	0.000349	CcSEcCtD
Acamprosate—Vomiting—Methylprednisolone—ulcerative colitis	0.000245	0.000348	CcSEcCtD
Acamprosate—Nausea—Hydrocortisone—ulcerative colitis	0.000243	0.000346	CcSEcCtD
Acamprosate—Rash—Triamcinolone—ulcerative colitis	0.000243	0.000346	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—ulcerative colitis	0.000243	0.000345	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—ulcerative colitis	0.000242	0.000345	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—ulcerative colitis	0.000242	0.000345	CcSEcCtD
Acamprosate—Urticaria—Prednisone—ulcerative colitis	0.000242	0.000344	CcSEcCtD
Acamprosate—Headache—Triamcinolone—ulcerative colitis	0.000241	0.000343	CcSEcCtD
Acamprosate—Headache—Methylprednisolone—ulcerative colitis	0.000241	0.000343	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—ulcerative colitis	0.000241	0.000342	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—ulcerative colitis	0.000241	0.000342	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—ulcerative colitis	0.000239	0.00034	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—ulcerative colitis	0.000239	0.00034	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—ulcerative colitis	0.000231	0.000329	CcSEcCtD
Acamprosate—Dizziness—Dexamethasone—ulcerative colitis	0.000231	0.000329	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ADRB2—ulcerative colitis	0.000231	0.000776	CbGpPWpGaD
Acamprosate—Nausea—Triamcinolone—ulcerative colitis	0.000229	0.000326	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—ulcerative colitis	0.000228	0.000325	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—JAK2—ulcerative colitis	0.000227	0.000766	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NFKB1—ulcerative colitis	0.000226	0.00076	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000224	0.000756	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisone—ulcerative colitis	0.000224	0.000319	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—ADCY5—ulcerative colitis	0.000224	0.000755	CbGpPWpGaD
Acamprosate—Vomiting—Betamethasone—ulcerative colitis	0.000222	0.000316	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—ulcerative colitis	0.000222	0.000316	CcSEcCtD
Acamprosate—Rash—Dexamethasone—ulcerative colitis	0.000221	0.000314	CcSEcCtD
Acamprosate—Rash—Betamethasone—ulcerative colitis	0.000221	0.000314	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—ulcerative colitis	0.00022	0.000313	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—ulcerative colitis	0.00022	0.000313	CcSEcCtD
Acamprosate—Headache—Dexamethasone—ulcerative colitis	0.000219	0.000312	CcSEcCtD
Acamprosate—Headache—Betamethasone—ulcerative colitis	0.000219	0.000312	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—JAK2—ulcerative colitis	0.000219	0.000737	CbGpPWpGaD
Acamprosate—Asthenia—Prednisone—ulcerative colitis	0.000219	0.000311	CcSEcCtD
Acamprosate—Pruritus—Prednisone—ulcerative colitis	0.000215	0.000306	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—JAK2—ulcerative colitis	0.000213	0.000719	CbGpPWpGaD
Acamprosate—Diarrhoea—Prednisone—ulcerative colitis	0.000208	0.000296	CcSEcCtD
Acamprosate—Nausea—Betamethasone—ulcerative colitis	0.000208	0.000295	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—ulcerative colitis	0.000208	0.000295	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000208	0.000699	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—JAK2—ulcerative colitis	0.000206	0.000695	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.000203	0.000684	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—ulcerative colitis	0.000203	0.000683	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.000201	0.000678	CbGpPWpGaD
Acamprosate—Dizziness—Prednisone—ulcerative colitis	0.000201	0.000286	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—IL2—ulcerative colitis	0.000198	0.000668	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADCY5—ulcerative colitis	0.000196	0.000659	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.000195	0.000656	CbGpPWpGaD
Acamprosate—Vomiting—Prednisone—ulcerative colitis	0.000194	0.000275	CcSEcCtD
Acamprosate—Rash—Prednisone—ulcerative colitis	0.000192	0.000273	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—ulcerative colitis	0.000192	0.000273	CcSEcCtD
Acamprosate—Headache—Prednisone—ulcerative colitis	0.000191	0.000271	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—ulcerative colitis	0.000188	0.000635	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—ulcerative colitis	0.000187	0.000629	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—ulcerative colitis	0.000182	0.000614	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000182	0.000612	CbGpPWpGaD
Acamprosate—Nausea—Prednisone—ulcerative colitis	0.000181	0.000257	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MMP9—ulcerative colitis	0.000181	0.000609	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—ulcerative colitis	0.00018	0.000607	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—ulcerative colitis	0.000176	0.000593	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—JAK2—ulcerative colitis	0.000156	0.000526	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—JAK2—ulcerative colitis	0.000152	0.000513	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RELA—ulcerative colitis	0.000151	0.00051	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.00015	0.000507	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000148	0.000498	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RELA—ulcerative colitis	0.000148	0.000497	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.000141	0.000476	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.00014	0.000473	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000138	0.000464	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000129	0.000435	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—ulcerative colitis	0.000129	0.000434	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NFKB1—ulcerative colitis	0.000128	0.00043	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—ulcerative colitis	0.000126	0.000423	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NFKB1—ulcerative colitis	0.000124	0.000419	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JAK2—ulcerative colitis	0.000122	0.000411	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000121	0.000406	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RELA—ulcerative colitis	0.000118	0.000398	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—ulcerative colitis	0.000115	0.000386	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.000114	0.000384	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—ulcerative colitis	0.000112	0.000378	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—ulcerative colitis	0.000112	0.000376	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—ulcerative colitis	0.000111	0.000375	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—ulcerative colitis	0.000109	0.000368	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—ulcerative colitis	0.000106	0.000358	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—ulcerative colitis	0.000106	0.000358	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—ulcerative colitis	0.000106	0.000357	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—ulcerative colitis	0.000104	0.000349	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—ulcerative colitis	0.000101	0.000339	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKB1—ulcerative colitis	9.96e-05	0.000336	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—ulcerative colitis	9.93e-05	0.000334	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—ulcerative colitis	9.68e-05	0.000326	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.41e-05	0.000317	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.24e-05	0.000311	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—ulcerative colitis	8.95e-05	0.000302	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—ulcerative colitis	8.3e-05	0.000279	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.08e-05	0.000272	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—ulcerative colitis	8.01e-05	0.00027	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—ulcerative colitis	7.81e-05	0.000263	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—ulcerative colitis	6.83e-05	0.00023	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—ulcerative colitis	6.25e-05	0.000211	CbGpPWpGaD
